Advanced Accelerator Applications

East Hanover,  NJ 
United States
https://www.virtualcongress.adacap.com/a21/

• Booth: 14027a

Advanced Accelerator Applications (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. Founded in 2002, AAA has a legacy as a pioneer in the development and delivery of radiopharmaceutical drugs for diagnostic imaging. More recently, AAA has focused its efforts on developing targeted radioligand therapies and precision imaging diagnostics that target specific markers that are over-expressed by certain types of solid tumors. AAA currently employs more than 1,100 associates across 31 sites in 12 countries, with 19 manufacturing facilities in 8 countries and 6 research and development sites.

Brands: https://events.jspargo.com/ASCO21/CUSTOM/aaabanner.png

 Press Releases

• Explore Our Virtual Congress Hub (May 26, 2021)
  https://www.virtualcongress.adacap.com/a21/

• Learn More About Precision Medicine in Neuroendocrine Tumors (May 26, 2021)
  https://www.virtualcongress.adacap.com/a21/neuroendocrine-tumors/

• Learn More About Precision Medicine in Prostate Cancer (May 26, 2021)
  https://www.virtualcongress.adacap.com/a21/prostate-cancer/

• See the AAA Scientific Presentations (May 26, 2021)
  https://www.virtualcongress.adacap.com/a21/scientific-presentations/

• View Our Approved Products (May 26, 2021)
  https://www.virtualcongress.adacap.com/a21/approved-products/